Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03694327 · ClinicalTrials.gov registry record · NA
Innovative Digital Therapeutic for Smoking Cessation
A NA study of Smoking Cessation and Tobacco Use Disorder, sponsored by My Digital Study.
- Completed
- Registry status
- NA
- Development phase
- 158
- Enrollment target
- 1
- Study location
NCT03694327: Completed NA study of Smoking Cessation and Tobacco Use Disorder, sponsored by My Digital Study.
NCT03694327 is a NA study of Smoking Cessation and Tobacco Use Disorder that has completed, run by My Digital Study. The registered enrollment target is 158 participants, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03694327, a NA study of Smoking Cessation and Tobacco Use Disorder, has completed, sponsored by My Digital Study.
- COMPLETED
- Registry status
- NA
- Development phase
- 158 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is comparing the efficacy of two smoking cessation apps.
Primary Outcome
Self-reported abstinence from smoking was assessed in the 8-Week Outcome Survey.
Conditions Studied
Interventions
- DEVICE CT-101-M
- DEVICE QuitGuide
Study Locations (1)
New York
- My Digital Study - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 158 participants |
| Start Date | 2018-10-24 |
| Est. Completion | 2019-03-14 |
| Phase | NA |
What the finished NCT03694327 record still lists
NCT03694327 is an interventional study that assigns participants to a tested intervention. The registered 158 participants enrollment target is mid-sized for trials with a published cap, below the 474-participant average among 188 other Smoking Cessation trials with a reported enrollment target (67% lower).
The record links to 8 conditions, with Smoking Cessation appearing as the primary indexed condition, and to 2 interventions - of which CT-101-M is the first listed.
NCT03694327 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03694327 about?
NCT03694327 is a clinical study titled "Innovative Digital Therapeutic for Smoking Cessation". This study is comparing the efficacy of two smoking cessation apps.
What is the current status of trial NCT03694327?
This trial is currently completed. It is a NA study. The enrollment target is 158 participants. The study started on 2018-10-24. Estimated completion is 2019-03-14.
What conditions does trial NCT03694327 study?
This clinical trial studies the following conditions: Smoking Cessation, Tobacco Use Disorder, Tobacco Smoking, Tobacco Dependence, Substance Use Disorder.
What interventions are being tested in trial NCT03694327?
The interventions under investigation include: CT-101-M (DEVICE), QuitGuide (DEVICE).
Who is sponsoring clinical trial NCT03694327?
This trial is sponsored by My Digital Study, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03694327 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking Cessation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03694327's enrollment target sits among peer trials
158 101st of 188 higher than 88 of 188 other Smoking Cessation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking Cessation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy
RECRUITING · NA
-
Scalable TELeheaLth Cancer CARe: The STELLAR Program to Treat Cancer Risk Behaviors
RECRUITING · NA
-
ACT Lung Health Intervention: Phase Two
RECRUITING · NA
-
Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
RECRUITING · NA
-
Baby Steps III: Testing a Clinician and Patient Intervention to Promote Smoking Cessation Among Pregnant Women
RECRUITING · NA
-
Urban and Reservation Implementation of All Nations Breath of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04486833 · 158 participants · Phase 1
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib
- NCT04697966 · 158 participants · NA
Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents
- NCT04969835 · 158 participants · Phase 1
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours
- NCT05230732 · 158 participants · NA
Neuromodulation of Inflammation and Endothelial Function
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI